Buying and Selling Specials in 2012 What the NHS customer wants How the contracting process helps them to get it Jane Page Principal Pharmacist Medicines.

Slides:



Advertisements
Similar presentations
Basic Principles of GMP
Advertisements

Kate Fox Commercial Manager BCM Specials Ltd. Conditions of manufacture and supply of unlicensed medicinal products Bona fide unsolicited order Product.
Key Performance Indicators
What are the challenges of successfully implementing homecare?
Selling to the Council.
SPS Quality Healthcheck: Supporting Customer Excellence.
Mike Keen, CEO, Kent LPC. Why is change needed? NHS England states that: Primary care services face increasingly unsustainable pressures Community pharmacy.
National Picture on Homecare Services Mark Hackett CEO Southampton University Hospitals NHS Trust.
Homecare Medicines: Reducing the risks Professor Ray Fitzpatrick Clinical Director of Pharmacy Royal Wolverhampton NHS Trust Co Chair Standards and Handbook.
10/05/ PDIG Award 2008/9: Purchasing for Safety – Injectable Medicines Dr Clare Crowley Lead Medicines Safety Pharmacist Oxford Radcliffe Hospitals.
Managing the Performance of Homecare Medicines Services Jane Kelly, Procurement Project Pharmacist Mick Butterfield, Specialist Technician: Homecare Medicines.
Role of Pharmacoeconomics in a Developing country context Gavin Steel for Anban Pillay Cluster Manager: Health Economics National Department of Health.
Auditing Homecare Suppliers Trevor Munton Regional QA Pharmacist.
PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007
Protecting patients- now and in the future Linda Matthew Senior Pharmacist National Patient Safety Agency.
Learning from GMP Inspections. Richard Bateman QA Specialist Pharmacist East and South East England Specialist Pharmacy Services.
Pharmacy & National Procurement Christine Gilmour Chief Pharmacist NHS Lanarkshire.
“SPECIALS” LEGAL BACKGROUND & INTRODUCTION TO GN14 Presented by Rob Lowe Director of Quality Assurance Specialist Services – East of England.
Procurement Workshop 27 th June 2012 Alison Riley Senior Procurement Officer.
Huzairy Hassan School of Bioprocess Engineering UniMAP.
Chairman, Pharmaceutical Market Support Group
Unlicensed Medicines in Paediatrics Is there a problem ? Scottish Neonatal and Paediatric Pharmacist Group National Paediatric Pre- Registration Pharmacist.
Contracting of Branded Medicines Philip Aubrey Chair – Branded Medicines Sub Group of PMSG PDIG Symposium 10 th Nov 2011.
Supplies by pharmacists to entities other than patients.
The standard setting programme of the GPhC Priya Sejpal.
Pharmacy Services.
PROCUREMENT & DISTRIBUTION INTEREST GROUP Autumn Symposium 2007
Working in partnership with Crescent Purchasing Consortium Buying Temporary & Teaching Staff 5 th May 2010.
London, Eastern and South East Specialist Pharmacy Services Clinical Pharmacy Clinical Governance & Technical Services Community Care Education & Training.
‘No Needless Medication Errors’
Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use.
Should we receive professional procurement training? Matt Condon Pharmacy Procurement Manager PDIG Autumn Symposium Thursday, 11 th November 2010.
Southampton City Council Schools Procurement Briefing July 2013 John Spiers Head of Property, Procurement and Contract Management.
Important informations
Robyn Tolley 16°July 2014 NHS England EPMA Webinar 1.
BNF for children and formulations Ian Costello British National Formulary.
NHS Greater Glasgow And Clyde - Achieving Good Equality Outcomes Gordon Beattie Head of Procurement.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
Robyn Tolley 19° November 2014 NHS England EPMA Webinar 1.
Molecule-to-Market-Place Quality
Development and Implementation of Good Pharmacy Practice Standards in Developing Countries Author: Frokjaer B, International Pharmaceutical Federation.
The pitfalls of pragmatic research: Pharm-assist: Using PDAs to assist in Pharmacy decisions Pip Divall Clinical Librarian University Hospitals of Leicester.
Compounding Kenneth Schell Pharm. D President, CA State Board of Pharmacy.
A Hospital without a Pharmacy - building a first class pharmacy service Anne Cope Associate Director of Pharmacy University Hospital Birmingham NHS Foundation.
GDJ Consultancy Ltd Gareth Jones –Director Telephone: Jan Hoskins- Procurement Manager Telephone:
Module 2Slide 1 of 26 WHO - EDM Quality Management Basic Principles of GMP Part One.
PROCUREMENT CASE FOR FRAMEWORKS SOUTH WEST CONSULTANCY FRAMEWORK WORKSHOP 24 February 2011 Taunton Colm Hughes Strategic Procurement Specialist Torbay.
Opportunities in 2012 and Beyond The Way Forward Stuart Semple Director of Pharmacy and Medicines Management Barts Health NHS Trust.
The OJEU Procurement Process: What a would-be NHS Supplier needs to do Dena Godward, Assistant Chief Pharmacist, Technical Services Barts Pharmaceuticals,
Achilles FPAL Overview Emily Broom Interim Sales Team Leader 2015.
Medicines Purchasing in Secondary Care in the NHS & the Market for Specials and Outsourced Services Kevan Wind, Medicines Procurement Specialist Pharmacist,
Clinical Pharmaceutical Science
1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014.
April 2016 RM1045 Network Services: Developing Your Invitation to Tender (ITT) / Request for Proposal (RfP) Document Set.
Commercial Medicines Unit (CMU)
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast The Challenge: Tendering for Unlicensed.
How Innovating for Health Could Benefit Patients and our Trusts’ Wealth What Could We Do Differently? Suzanne Goodband
RAC Regulatory Affairs Certification
QUALITY ASSURANCE.
Nonsterile compounding-USP ch 795
The importance of Procurement for Wales and Welsh Business
Quality Assurance and Quality Control in Generics
Inter-Agency Guidelines for Good Procurement of Pharmaceuticals
Nonsterile compounding-USP ch 795
Introduction to GMP.
Nonsterile compounding-USP ch 795
Low Value Contracts Procurement Week 2013 Aileen Murtagh A&L Goodbody
Evaluation of the Use and Knowledge of Unlicensed Medication
Compounded Drugs and Lack of Premarket FDA-Approval
Hospital pharmacy.
Presentation transcript:

Buying and Selling Specials in 2012 What the NHS customer wants How the contracting process helps them to get it Jane Page Principal Pharmacist Medicines Procurement University Hospitals of Leicester

NHS Customer…

The view from here UHL - large NHS Trust (not yet an FT) - no pharmacy production unit East Midlands - other large Trusts with production units - no “Regional” production unit - modernisation money went into QA

Unlicensed Medicines Seemingly undiminished need Over 10% of drug catalogue unlicensed A big headache for procurement staff

What does the NHS Customer want? The NHS customer – THE PATIENT wants Safe medicine Effective medicine Available when needed Low cost (it’s taxpayers’ money)

How do we ensure SAFETY ? Chief Pharmacist responsibility Trust Unlicensed Medicines Policy Risk Assessment Clinical risk – evidence for use, risk of harm, side effects, therapeutic window Pharmaceutical risk – source of supply, production process, product specification and QA Bond and release process on receipt

How does the procurement process ensure delivery of safe medicines on time? Choice of supplier – appropriately licensed, QA audited, performance record Product specifications Certificates of Analysis.....but are we getting the best price?

How easy is all this? ProFile is really useful Manufacturers’ information more readily available BUT More and more companies knocking on the door Competitive pricing Need for quality assurance

Contracting Stops the doorbell ringing Stable source of supply Improves quality assurance Ensures value for money Meets EU and public sector procurement rules Any qualified provider

Contracting Process Service to supply unlicensed medicines Includes examples of products required and potential volumes EM contracts for unlicensed medicines are framework contracts with a number of suppliers awarded to the framework. Each supplier is awarded specified products and volumes, with any new products required subject to mini-competition

Contracting Process Advertisement – we find out how many potential suppliers there are PQQ – checks suppliers are qualified to tender ITT – detailed specification of service required. Allows suppliers to tell us in detail what they can deliver Evaluation of supplier offers Adjudication – side by side comparison of offers Award Implementation Contract Management and KPIs

What are we looking for? Quality Management System Evidence of control of raw materials, production process, QC, finished products, staff training, documentation Products which meet specification Labelling in accordance with NPSA guidance Flexibility to change labels to meet our needs Certificates of Analysis

Evaluation ITT – answer questions fully and include relevant documentation as evidence Products – samples should be correctly labelled and packaged as for hospital delivery Documentation – product specification, stability data, Cof A Presentation – make it relevant Contingency plans Price – evaluated last

Categories Dose banded chemotherapy “ready to use” injectables Infusions for home delivery Imported medicines (unlicensed) Specials (UK compounded unlicensed medicines)

Thank you and any questions?